NUTX
Nutex Health Inc
220.10$
+7.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 92.7% | 100.0% | 99.4% | 1.7% | 68.0% | 25.5% | 43.9% | 39.0% | 22.7% | 22.8% | 44.6% | 58.7% | |
| 47.5% | 1.6% | 2.1% | 0.3% | 26.5% | 4.5% | 8.3% | 9.2% | 7.9% | 5.5% | 6.7% | 20.2% | |
| 47.5% | 1.6% | 2.1% | 0.3% | 26.5% | 4.5% | 8.3% | 9.2% | 7.9% | 5.5% | 6.7% | 20.2% | |
| 29.1% | – | 2.9% | 0.2% | 41.4% | 20.2% | 35.0% | 29.1% | 13.5% | 15.8% | 36.0% | 35.4% | |
| – | – | – | – | 6.0% | 0.5% | 0.6% | 0.7% | 0.8% | 0.9% | 0.4% | 0.3% | |
| – | – | – | – | – | 73.2% | 55.4% | 60.4% | 19.0% | – | – | – | |
| – | – | – | – | – | 1.9% | 0.4% | 0.3% | 3.9% | 4.3% | 2.1% | 1.5% | |
| – | – | – | 98.2% | 572.3% | 0.9% | – | 0.2% | 4.9% | 5.2% | 2.4% | 2.3% | |
| 101.6% | 79.6% | 1,249.0% | 28.8% | 433.2% | 71.6% | 52.2% | 51.5% | 72.1% | 80.1% | 69.2% | 53.9% | |
| 101.6% | 79.6% | 1,249.0% | 28.8% | 232.3% | 40.2% | 10.2% | 9.6% | 12.7% | 14.6% | 21.5% | 17.2% | |
| – | – | 9.8% | 11.6% | 106.1% | 35.5% | 6.6% | 3.3% | 4.9% | 5.0% | 4.2% | 2.5% | |
| 101.6% | 2.2% | 69.7% | 10.5% | 126.2% | 1.0% | 2.8% | 4.5% | 5.5% | 6.3% | 2.1% | 5.3% | |
| – | – | – | – | – | 22.8% | 26.5% | 20.0% | 5.3% | 6.6% | 3.4% | 3.2% | |
| -1.6% | 20.4% | -1,149.0% | 71.2% | -333.2% | 15.8% | 27.8% | 29.1% | 22.2% | 15.4% | 22.3% | 35.9% | |
| -1,026.5% | -36.6% | -2,002.7% | -289.9% | -1,213.2% | -7.0% | -5.9% | 25.9% | -84.1% | -102.7% | -54.5% | -31.2% | |
| 0.1% | 27.0% | 404.4% | 125.7% | 1,598.5% | 2.3% | 1.4% | 1.0% | 1.0% | 1.1% | 0.8% | 0.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.